InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $2.110 0.01 (0.48%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$781 FY16 Market Briefing Q&A 25 Aug 2016 8:44AM $1.760 $2.090 risen by 18.75%
$781 Media Release FY16 Results 25 Aug 2016 8:39AM $1.760 $2.090 risen by 18.75%
$781 Dividend/Distribution - IDX 25 Aug 2016 8:34AM $1.760 $2.090 risen by 18.75%
$781 Appendix 4E - Preliminary Final Report YE 30 June 2016 25 Aug 2016 8:29AM $1.760 $2.090 risen by 18.75%
$781 Voluntary Escrow Release (Amendment) 25 Aug 2016 8:10AM $1.760 $2.090 risen by 18.75%
$781 Voluntary Escrow Release 16 Aug 2016 3:39PM $1.705 $2.090 risen by 22.58%
$781 Integral Diagnostics Limited 2016 Full Year Result 28 Jul 2016 9:10AM $1.610 $2.090 risen by 29.81%
$781 Appendix 3B 1 Jul 2016 2:41PM $1.460 $2.090 risen by 43.15%
$781 s708 Cleansing Statement 1 Jul 2016 2:40PM $1.460 $2.090 risen by 43.15%
$781 Change in substantial holding 21 Jun 2016 5:00PM $1.450 $2.090 risen by 44.14%
$781 Morgan Stanley Australian Emerging Companies Conference 15 Jun 2016 8:20AM $1.490 $2.090 risen by 40.27%
$781 Ceasing to be a substantial holder from PPT 12 May 2016 4:18PM $1.410 $2.090 risen by 48.23%
$781 IDX to acquire Western District Radiology and South West MRI 12 May 2016 8:29AM $1.380 $2.090 risen by 51.45%
$781 Becoming a substantial holder 6 May 2016 5:10PM $1.400 $2.090 risen by 49.29%
$781 Change in substantial holding from PPT 30 Mar 2016 4:12PM $1.385 $2.090 risen by 50.90%
$781 H1 FY2016 Post-Result Roadshow 15 Mar 2016 8:36AM $1.385 $2.090 risen by 50.90%
$781 S&P DJ Indices Announces March Quarterly Review 11 Mar 2016 8:25AM $1.360 $2.090 risen by 53.68%
$781 Change in substantial holding from PPT 10 Mar 2016 5:37PM $1.360 $2.090 risen by 53.68%
$781 Change in substantial holding - PPT 3 Mar 2016 4:20PM $1.270 $2.090 risen by 64.57%
$781 Becoming a substantial holder 1 Mar 2016 3:08PM $1.300 $2.090 risen by 60.77%
$781 CEO & CFO Presentation of Half Year Results 24 Feb 2016 8:14AM $1.500 $2.090 risen by 39.33%
$781 Half Year Market Briefing Q&A 24 Feb 2016 8:14AM $1.500 $2.090 risen by 39.33%
$781 Media Release Half Year Results 24 Feb 2016 8:14AM $1.500 $2.090 risen by 39.33%
$781 Half Yearly Report and Accounts 24 Feb 2016 8:13AM $1.500 $2.090 risen by 39.33%
$781 Integral Diagnostics Limited 2016 Interim Result 4 Feb 2016 12:39PM $1.520 $2.090 risen by 37.50%

726 - 750 of 788 results

Page 30 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.